Cargando…
Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
OBJECTIVES: The aim of this study was to examine the natural history of brain involvement in adult-onset myotonic dystrophies type 1 and 2 (DM1, DM2). METHODS: We conducted a longitudinal observational study to examine functional and structural cerebral changes in myotonic dystrophies. We enrolled 1...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405094/ https://www.ncbi.nlm.nih.gov/pubmed/30845252 http://dx.doi.org/10.1371/journal.pone.0213381 |
_version_ | 1783401011433439232 |
---|---|
author | Gliem, Carla Minnerop, Martina Roeske, Sandra Gärtner, Hanna Schoene-Bake, Jan-Christoph Adler, Sandra Witt, Juri-Alexander Hoffstaedter, Felix Schneider-Gold, Christiane Betz, Regina C. Helmstaedter, Christoph Tittgemeyer, Marc Amunts, Katrin Klockgether, Thomas Weber, Bernd Kornblum, Cornelia |
author_facet | Gliem, Carla Minnerop, Martina Roeske, Sandra Gärtner, Hanna Schoene-Bake, Jan-Christoph Adler, Sandra Witt, Juri-Alexander Hoffstaedter, Felix Schneider-Gold, Christiane Betz, Regina C. Helmstaedter, Christoph Tittgemeyer, Marc Amunts, Katrin Klockgether, Thomas Weber, Bernd Kornblum, Cornelia |
author_sort | Gliem, Carla |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to examine the natural history of brain involvement in adult-onset myotonic dystrophies type 1 and 2 (DM1, DM2). METHODS: We conducted a longitudinal observational study to examine functional and structural cerebral changes in myotonic dystrophies. We enrolled 16 adult-onset DM1 patients, 16 DM2 patients, and 17 controls. At baseline and after 5.5 ± 0.4 years participants underwent neurological, neuropsychological, and 3T-brain MRI examinations using identical study protocols that included voxel-based morphometry and diffusion tensor imaging. Data were analyzed by (i) group comparisons between patients and controls at baseline and follow-up, and (ii) group comparisons using difference maps (baseline–follow-up in each participant) to focus on disease-related effects over time. RESULTS: We found minor neuropsychological deficits with mild progression in DM1 more than DM2. Daytime sleepiness was restricted to DM1, whereas fatigue was present in both disease entities and stable over time. Comparing results of cross-sectional neuroimaging analyses at baseline and follow-up revealed an unchanged pattern of pronounced white matter alterations in DM1. There was mild additional gray matter reduction in DM1 at follow-up. In DM2, white matter reduction was of lesser extent, but there were some additional alterations at follow-up. Gray matter seemed unaffected in DM2. Intriguingly, longitudinal analyses using difference maps and comparing them between patients and controls did not reveal any significant differences of cerebral changes over time between patients and controls. CONCLUSION: The lack of significant disease-related progression of gray and white matter involvement over a period of five years in our cohort of DM1 and DM2 patients suggests either a rather slowly progressive process or even a stable course of cerebral changes in middle-aged adult-onset patients. Being the first longitudinal neuroimaging trial in DM1 and DM2, this study provides useful additional information regarding the natural history of brain involvement. |
format | Online Article Text |
id | pubmed-6405094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-64050942019-03-17 Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study Gliem, Carla Minnerop, Martina Roeske, Sandra Gärtner, Hanna Schoene-Bake, Jan-Christoph Adler, Sandra Witt, Juri-Alexander Hoffstaedter, Felix Schneider-Gold, Christiane Betz, Regina C. Helmstaedter, Christoph Tittgemeyer, Marc Amunts, Katrin Klockgether, Thomas Weber, Bernd Kornblum, Cornelia PLoS One Research Article OBJECTIVES: The aim of this study was to examine the natural history of brain involvement in adult-onset myotonic dystrophies type 1 and 2 (DM1, DM2). METHODS: We conducted a longitudinal observational study to examine functional and structural cerebral changes in myotonic dystrophies. We enrolled 16 adult-onset DM1 patients, 16 DM2 patients, and 17 controls. At baseline and after 5.5 ± 0.4 years participants underwent neurological, neuropsychological, and 3T-brain MRI examinations using identical study protocols that included voxel-based morphometry and diffusion tensor imaging. Data were analyzed by (i) group comparisons between patients and controls at baseline and follow-up, and (ii) group comparisons using difference maps (baseline–follow-up in each participant) to focus on disease-related effects over time. RESULTS: We found minor neuropsychological deficits with mild progression in DM1 more than DM2. Daytime sleepiness was restricted to DM1, whereas fatigue was present in both disease entities and stable over time. Comparing results of cross-sectional neuroimaging analyses at baseline and follow-up revealed an unchanged pattern of pronounced white matter alterations in DM1. There was mild additional gray matter reduction in DM1 at follow-up. In DM2, white matter reduction was of lesser extent, but there were some additional alterations at follow-up. Gray matter seemed unaffected in DM2. Intriguingly, longitudinal analyses using difference maps and comparing them between patients and controls did not reveal any significant differences of cerebral changes over time between patients and controls. CONCLUSION: The lack of significant disease-related progression of gray and white matter involvement over a period of five years in our cohort of DM1 and DM2 patients suggests either a rather slowly progressive process or even a stable course of cerebral changes in middle-aged adult-onset patients. Being the first longitudinal neuroimaging trial in DM1 and DM2, this study provides useful additional information regarding the natural history of brain involvement. Public Library of Science 2019-03-07 /pmc/articles/PMC6405094/ /pubmed/30845252 http://dx.doi.org/10.1371/journal.pone.0213381 Text en © 2019 Gliem et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Gliem, Carla Minnerop, Martina Roeske, Sandra Gärtner, Hanna Schoene-Bake, Jan-Christoph Adler, Sandra Witt, Juri-Alexander Hoffstaedter, Felix Schneider-Gold, Christiane Betz, Regina C. Helmstaedter, Christoph Tittgemeyer, Marc Amunts, Katrin Klockgether, Thomas Weber, Bernd Kornblum, Cornelia Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study |
title | Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study |
title_full | Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study |
title_fullStr | Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study |
title_full_unstemmed | Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study |
title_short | Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study |
title_sort | tracking the brain in myotonic dystrophies: a 5-year longitudinal follow-up study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405094/ https://www.ncbi.nlm.nih.gov/pubmed/30845252 http://dx.doi.org/10.1371/journal.pone.0213381 |
work_keys_str_mv | AT gliemcarla trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT minneropmartina trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT roeskesandra trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT gartnerhanna trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT schoenebakejanchristoph trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT adlersandra trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT wittjurialexander trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT hoffstaedterfelix trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT schneidergoldchristiane trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT betzreginac trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT helmstaedterchristoph trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT tittgemeyermarc trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT amuntskatrin trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT klockgetherthomas trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT weberbernd trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy AT kornblumcornelia trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy |